Factors Affecting Smoking Resumption After Acute Coronary Syndromes

被引:0
|
作者
Vogiatzis, Ioannis [1 ]
Tsikrika, Evangelia [1 ]
Sachpekidis, Vasilios [1 ]
Pittas, Sarantis [1 ]
Kotsani, Athina [1 ]
机构
[1] Gen Hosp Veria, Dept Cardiol, Smoking Cessat Clin, Thessaloniki, Greece
关键词
Acute coronary syndromes; smoking cessation; dependency; smoking cessation clinics; RANDOMIZED CONTROLLED-TRIAL; FOLLOW-UP; MYOCARDIAL-INFARCTION; HEART-DISEASE; QUITTING SMOKING; BYPASS-SURGERY; CESSATION; INTERVENTION; PREDICTORS; MORTALITY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Many patients who are hospitalised for acute ischaemic episodes stop smoking; however, many of them relapse and resume smoking again within three months from their hospitalisation. The aim of this study was to study the factors that might affect smoking resumption in patients who have suffered an acute coronary syndrome. Methods: We studied 420 patients, active smokers at the time of admission, who were hospitalised for an acute coronary episode. The patients' data (history, risk factors, smoking habits) were retrieved from their medical files. During their hospitalisation they were asked to stop smoking and to attend the smoking cessation clinic to be advised about this. The patients were followed for one year and logistic regression analysis was used to evaluate the independent predictors of smoking resumption and continuation. Results: Of the total patient population, 280 (66.67%) visited the smoking cessation clinic and followed a special programme. Most relapses were recorded during the first 3 months of follow up, after which time 223 (53.1%) were still smoking, compared with 256 (61.43%) at 1 year. Independent predictors of smoking resumption were: non-participation in the smoking cessation programme (odds ratio, OR: 4.32, p=0.0007); the use of antidepressants (OR: 2.28, p=0.01); a history of vascular disease (OR: 2.32, p=0.03); a history of chronic obstructive pulmonary disease (OR: 1.35, p=0.001; and a decree of nicotine dependency >8 on the Fagerstrom scale, as recorded in questionnaires (OR: 1.42, p=0.04). Conclusions: Smokers with acute coronary syndromes should be encouraged to participate in special secondary prevention programmes. Smoking cessation clinics contribute significantly to a reduction in smoking in this group of patients.
引用
收藏
页码:294 / 300
页数:7
相关论文
共 50 条
  • [31] Role of coronary risk factors in blood thrombogenicity and acute coronary syndromes
    Sambola, A
    Fuster, V
    Badimon, JJ
    REVISTA ESPANOLA DE CARDIOLOGIA, 2003, 56 (10): : 1001 - 1009
  • [32] Acute coronary syndromes or acute frailty syndromes?
    Ambrosetti, Marco
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2018, 25 (17) : 1811 - 1812
  • [33] IS THERE A GENDER DIFFERENCE IN THE TREATMENT DECISION AFTER CORONARY ANGIOGRAPHY FOR ACUTE ACUTE CORONARY SYNDROMES?
    Zeymer, Uwe
    Heer, Tobias
    Gitt, Anselm
    Senges, Jochen
    Hochadel, Matthias
    Zahn, Ralf
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A84 - A84
  • [34] Adherence to medications by patients after acute coronary syndromes
    Sud, A
    Kline-Rogers, EM
    Eagle, KA
    Fang, JM
    Armstrong, DF
    Rangarajan, K
    Otten, RF
    Stafkey-Mailey, DR
    Taylor, SD
    Erickson, SR
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (11) : 1792 - 1797
  • [35] Ezetimibe plus a Statin after Acute Coronary Syndromes
    Egom, Emmanuel E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (15): : 1474 - 1474
  • [36] Management of cardiogenic shock after acute coronary syndromes
    Milne, B.
    Dalzell, J. R.
    Kunst, G.
    BJA EDUCATION, 2023, 23 (05) : 172 - 181
  • [37] Abdominal obesity and outcomes after acute coronary syndromes
    Nabais, S.
    Rocha, S.
    Gaspar, A.
    Ribeiro, S.
    Costa, J.
    Azevedo, P.
    Alvares Pereira, M.
    Correia, A.
    EUROPEAN HEART JOURNAL, 2009, 30 : 480 - 480
  • [38] Lipoprotein(a) is not associated with survival after acute coronary syndromes
    Roth, C.
    Dalos, D.
    Gangl, C.
    Krychtiuk, K.
    Schrutka, L.
    Distelmaier, K.
    Wojta, J.
    Hengstenberg, C.
    Berger, R.
    Speidl, W.
    EUROPEAN HEART JOURNAL, 2019, 40 : 2790 - 2790
  • [39] Novel Oral Anticoagulants After Acute Coronary Syndromes
    Wiggins, Newton B.
    Granger, Christopher B.
    Alexander, John H.
    CARDIOVASCULAR DRUGS AND THERAPY, 2012, 26 (03) : 265 - 271
  • [40] Risk factor management after acute coronary syndromes
    Melloni, Chiara
    Newby, L. Kristin
    HEART, 2009, 95 (17) : 1382 - 1384